230 results
8-K
EX-99.1
XTNT
Xtant Medical Holdings Inc
15 May 24
Xtant Medical Reports First Quarter 2024 Revenue Growth of 55% and Raises Full Year 2024 Revenue Guidance
4:15pm
,
Net Loss
Depreciation and amortization
Interest expense
Tax expense
Non-GAAP EBITDA/Total revenue
NON-GAAP ADJUSTED EBITDA CALCULATION
Non-cash
8-K
XTNT
Xtant Medical Holdings Inc
15 May 24
Xtant Medical Reports First Quarter 2024 Revenue Growth of 55% and Raises Full Year 2024 Revenue Guidance
4:15pm
by adding back to net loss the charges for depreciation and amortization expense, interest expense, and tax expense and further adjusted by adding back
8-K
EX-99.1
gk23i2972io030qdo6
1 Apr 24
Xtant Medical Announces Record Full Year 2023 Revenue of $91.3 Million
7:05am
8-K
EX-10.2
ksbsn49dji3aaj
7 Mar 24
Entry into a Material Definitive Agreement
5:13pm
8-K
EX-10.1
xir4fd1xd5nh8 4bg
7 Mar 24
Entry into a Material Definitive Agreement
5:13pm
8-K
px4qd17 nq
9 Nov 23
Xtant Medical Announces Record Third Quarter Revenue of $25 Million
7:15am
8-K
EX-99.1
7r8m61w uygz
9 Nov 23
Xtant Medical Announces Record Third Quarter Revenue of $25 Million
7:15am
8-K/A
EX-99.1
hsieuismpko7
26 Oct 23
Financial Statements and Exhibits
4:05pm
8-K/A
EX-99.2
vm4sggmv
26 Oct 23
Financial Statements and Exhibits
4:05pm